开云app官网登录入口网页版-官方正版

#塞利尼索#

0篇内容 | 580人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2211392, encodeId=d023221139264, content=<a href='/topic/show?id=9ad2111e516c' target=_blank style='color:#2F92EE;'>#髓源性抑制细胞#</a> <a href='/topic/show?id=6e87188525c' target=_blank style='color:#2F92EE;'>#XPO1#</a> <a href='/topic/show?id=1bf011141e3e' target=_blank style='color:#2F92EE;'>#塞利尼索#</a>, objectTitle=Cell Mol Immunol：新研究发现XPO1蛋白控制肿瘤中髓源性抑制细胞的免疫抑制功能, objectType=article, longId=831525, objectId=0cc683152575, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240623/1719144313361_2185383.png, objectUrl=/article/show_article.do?id=0cc683152575, replyNumber=0, likeNumber=34, createdTime=2024-06-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2209746, encodeId=5eaa2209e462d, content=<a href='/topic/show?id=1bf011141e3e' target=_blank style='color:#2F92EE;'>#塞利尼索#</a> <a href='/topic/show?id=c8431154e5fb' target=_blank style='color:#2F92EE;'>#2024 EHA#</a>, objectTitle=2024 EHA｜中国之声：塞利尼索重磅成果一览, objectType=article, longId=829591, objectId=f3d382959124, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240606/1717679081671_8624274.png, objectUrl=/article/show_article.do?id=f3d382959124, replyNumber=0, likeNumber=68, createdTime=2024-06-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f3d382959124, moduleTitle=2024 EHA｜中国之声：塞利尼索重磅成果一览, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f3d382959124)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188739, encodeId=fb612188e39c8, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=a4671201218' target=_blank style='color:#2F92EE;'>#MM#</a> <a href='/topic/show?id=a04e4135027' target=_blank style='color:#2F92EE;'>#地塞米松#</a> <a href='/topic/show?id=7f389396e27' target=_blank style='color:#2F92EE;'>#达雷妥尤单抗#</a> <a href='/topic/show?id=1bf011141e3e' target=_blank style='color:#2F92EE;'>#塞利尼索#</a>, objectTitle=【Haematologica】塞利尼索+达雷妥尤单抗+Vd治疗RRMM的II期研究, objectType=article, longId=814080, objectId=882f81408000, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing-D3K6QME.jpg, objectUrl=/article/show_article.do?id=882f81408000, replyNumber=0, likeNumber=78, createdTime=2024-02-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=882f81408000, moduleTitle=【Haematologica】塞利尼索+达雷妥尤单抗+Vd治疗RRMM的II期研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=882f81408000)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

多发性骨髓瘤 MM 地塞米松达雷妥尤单抗塞利尼索

2024-02-22发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#髓源性抑制细胞# #XPO1# #塞利尼索#

2024-06-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#塞利尼索# #2024 EHA#

2024 EHA｜中国之声：塞利尼索重磅成果一览

2024-06-13发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #MM# #地塞米松# #达雷妥尤单抗# #塞利尼索#

【Haematologica】塞利尼索+达雷妥尤单抗+Vd治疗RRMM的II期研究

2024-02-22发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务